Brokers Offer Predictions for Allstate FY2024 Earnings

The Allstate Co. (NYSE:ALL) – Investment analysts at Zacks Research issued their FY2024 EPS estimates for Allstate in a report released on Wednesday, November 13th. Zacks Research analyst Z. Masood expects that the insurance provider will earn $15.42 per share for the year. The consensus estimate for Allstate’s current full-year earnings is $16.01 per share. Zacks Research also issued estimates for Allstate’s Q2 2025 earnings at $2.94 EPS, Q3 2025 earnings at $3.91 EPS, Q4 2025 earnings at $4.68 EPS, FY2025 earnings at $16.64 EPS, Q1 2026 earnings at $5.19 EPS and Q2 2026 earnings at $3.46 EPS.

Other equities analysts have also issued research reports about the stock. BMO Capital Markets increased their price objective on shares of Allstate from $205.00 to $214.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. Roth Mkm reiterated a “buy” rating and set a $200.00 price objective on shares of Allstate in a research report on Wednesday, August 14th. Raymond James upped their price objective on Allstate from $205.00 to $220.00 and gave the company a “strong-buy” rating in a research report on Friday, October 4th. Morgan Stanley upped their price target on shares of Allstate from $220.00 to $228.00 and gave the stock an “overweight” rating in a report on Thursday, November 7th. Finally, The Goldman Sachs Group upped their target price on shares of Allstate from $209.00 to $230.00 and gave the stock a “buy” rating in a research note on Friday. One analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $214.19.

Allstate Stock Performance

NYSE:ALL opened at $196.88 on Monday. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.40 and a quick ratio of 0.40. The company has a market cap of $52.13 billion, a price-to-earnings ratio of 12.75, a PEG ratio of 1.75 and a beta of 0.48. Allstate has a 1 year low of $131.65 and a 1 year high of $201.00. The stock’s 50 day simple moving average is $190.01 and its two-hundred day simple moving average is $176.80.

Allstate (NYSE:ALL) last issued its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, beating analysts’ consensus estimates of $2.20 by $1.71. The firm had revenue of $16.63 billion during the quarter, compared to analyst estimates of $14.57 billion. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The business’s quarterly revenue was up 14.7% compared to the same quarter last year. During the same quarter last year, the business posted $0.81 earnings per share.

Allstate Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th will be paid a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a dividend yield of 1.87%. The ex-dividend date of this dividend is Friday, November 29th. Allstate’s dividend payout ratio (DPR) is presently 23.83%.

Insider Activity

In other Allstate news, insider John E. Dugenske sold 36,367 shares of the stock in a transaction dated Friday, September 20th. The stock was sold at an average price of $191.38, for a total value of $6,959,916.46. Following the sale, the insider now owns 27,364 shares of the company’s stock, valued at $5,236,922.32. This trade represents a 57.06 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Thomas J. Wilson sold 90,000 shares of Allstate stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the completion of the transaction, the chief executive officer now owns 88,552 shares of the company’s stock, valued at $15,880,915.68. This represents a 50.41 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.80% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the stock. BDF Gestion purchased a new position in shares of Allstate during the second quarter worth about $3,051,000. OFI Invest Asset Management acquired a new position in Allstate during the 2nd quarter worth approximately $476,000. Cetera Investment Advisers lifted its holdings in shares of Allstate by 351.6% in the 1st quarter. Cetera Investment Advisers now owns 65,221 shares of the insurance provider’s stock valued at $11,284,000 after buying an additional 50,780 shares during the period. Diversified Trust Co grew its holdings in Allstate by 505.3% during the second quarter. Diversified Trust Co now owns 7,923 shares of the insurance provider’s stock worth $1,265,000 after acquiring an additional 6,614 shares during the period. Finally, Canada Pension Plan Investment Board lifted its holdings in Allstate by 97.5% in the first quarter. Canada Pension Plan Investment Board now owns 271,464 shares of the insurance provider’s stock valued at $46,966,000 after acquiring an additional 134,028 shares during the period. 76.47% of the stock is owned by hedge funds and other institutional investors.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.